We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Jardiance to Improve Glycemic Control in Type 2 Diabetes
FDA Approves Jardiance to Improve Glycemic Control in Type 2 Diabetes
The FDA approved Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, reversing its rejection this spring based on quality concerns at one of BI’s plants where the drug is made.